| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Clover Health Investments Corp (NASDAQ:CLOV) shares are trading higher in Thursday’s after-hours session following insider buying from the company’s co-founder.
What Happened: After the market close on Thursday, Clover Health filed a Form 4 with the SEC showing that co-founder and executive chair Vivek Garipalli purchased 877,567 shares of Clover Health stock at an average price of $1.14 per share.
The shares were bought on June 17 in multiple transactions at prices ranging from $1.08 to $1.17.
Clover Health is a healthcare technology company focused on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform Clover Assistant.
From Last Month: Clover Health Investments And 2 Other Stocks Under $1 Insiders Are Buying
Besides going to a brokerage platform to purchase a share — or fractional share — of stock, you can also gain access to shares either by buying an exchange-traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, Clover Health is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
CLOV Price Action: Clover Health shares were up 9.71% at $1.13 in after-hours trading at publication time, according to Benzinga Pro.
Photo: Shutterstock.
Posted In: CLOV
